In the context of COVID-19, peripheral immune profiling has revealed increased CX3CR1 expression on monocytes—suggesting enhanced chemotactic potential and neuroimmune crosstalk consistent with neuroinflammatory features observed in our transcriptomic analyses [41]. This evidence concerns the gene CX3CR1 and COVID-19.